Ortho Regenerative Technologies Inc. announced the appointment of François-Xavier Lacasse, Ph.D., to its senior management team in the newly created position of vice president of product development. Dr. Lacasse's mandate will be the development and execution of a comprehensive product development program for the company's novel therapeutic tissue repair devices, including the streamlining of the company's preclinical, chemistry, manufacturing, quality control and regulatory affairs activities. Dr. Lacasse brings over 20 years of drug development experience to the company. Prior to joining the company, he held senior consulting and executive leaderships positions with a number of companies, including Anapharm Inc., Xanthus Life Sciences Inc., Supratek Pharma Inc., Merck Frosst and LAB Pharmaceutical Research.